H35.3193 Nonexudative age-related macular degeneration, unspecified eye, advanced atrophic without subfoveal involvement

Name of the Condition

• Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Advanced Atrophic Without Subfoveal Involvement

Summary

Nonexudative age-related macular degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp central vision. It is characterized by gradual macular degeneration without fluid leakage or bleeding, leading to blurred or reduced vision. This form of AMD is also commonly referred to as "dry AMD." The unspecified eye and advanced atrophic stage without subfoveal involvement indicate that the condition is not localized to a specific eye and has progressed to advanced atrophy, with no involvement of the subfoveal area.

Causes

The exact cause of nonexudative AMD is not fully understood, but it involves the degeneration of retinal cells and the accumulation of drusen (yellow deposits) under the retina. Oxidative stress and inflammation in retinal tissues are also believed to contribute to the condition.

Risk Factors

• Increasing age, especially over 50.
• Family history of macular degeneration.
• Smoking and tobacco use.
• Obesity and high cholesterol.
• Lack of exercise and poor diet lacking antioxidants and zinc.

Symptoms

• Blurred or reduced central vision.
• Difficulty recognizing faces or reading.
• Need for brighter lighting when working or reading.
• Haziness in overall vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilation, to assess the macula. Optical coherence tomography (OCT) is used to visualize retinal layers, and an Amsler grid test detects vision distortions. Fundus photography may document drusen and atrophy.

Treatment Options

Treatment focuses on slowing progression and managing symptoms. Options include antioxidant supplements (e.g., vitamins C, E, zinc, and lutein), lifestyle modifications, and low-vision aids. Advanced cases may involve monitoring for conversion to exudative AMD.

Prognosis and Follow-Up

Prognosis depends on the rate of progression. Regular follow-up with an ophthalmologist is essential to monitor for vision changes and detect complications. Early intervention can help preserve remaining vision.

Complications

Complications may include severe central vision loss, difficulty with daily activities (e.g., reading, driving), and increased risk of developing exudative AMD, which can cause rapid vision decline.

Lifestyle & Prevention

• Quit smoking and avoid tobacco exposure.
• Maintain a healthy diet rich in antioxidants and omega-3 fatty acids.
• Exercise regularly and manage weight.
• Protect eyes from excessive UV light with sunglasses.
• Monitor vision using an Amsler grid and report changes promptly.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, such as blurriness, distortion, or dark spots, as these may indicate progression to exudative AMD or other serious conditions.

Tips for Medical Coders

Document the eye (unspecified) and specify "advanced atrophic without subfoveal involvement" to accurately reflect the condition. Ensure clinical notes support the absence of subfoveal involvement and the advanced atrophic stage. Use this code when the condition is not localized to a specific eye and meets the described criteria.